| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $161.7M | +14.6% | +92.8% |
| Cost of Revenue | $28.1M | +48.3% | +200.7% |
| R&D Expense | $40.9M | +28.6% | +103.0% |
| SG&A Expense | $63.4M | +14.0% | +51.0% |
| Operating Income | $29.4M | -15.7% | +136.2% |
| Pre-tax Income | $25.9M | -16.2% | +507.1% |
| Income Tax | -$365.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $74.1M | -42.6% | -62.2% |
| Short-term Investments | $57.5M | -53.2% | -60.4% |
| Accounts Receivable | $265.4M | +14.6% | +129.3% |
| Inventory | $147.0M | -5.3% | +73.6% |
| Current Assets | $599.8M | -9.7% | +4.5% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$44.4M | — | — |
| Capital Expenditures | $147K | — | — |
| Investing Cash Flow | $29.4M | — | — |
| Financing Cash Flow | -$90.8M | — | — |
| Free Cash Flow | -$44.6M | — | — |
| — |
| — |
| Net Income | $390.9M | +1286.8% | +9974.6% |
| EPS (Basic) | $2.69 | +1315.8% | +8866.7% |
| EPS (Diluted) | $2.43 | +1329.4% | — |
| $1.03B |
| +45.9% |
| +74.9% |
| Current Liabilities | $156.8M | -8.8% | +25.3% |
| Long-term Debt | $245.3M | +0.1% | +0.5% |
| Total Liabilities | $417.8M | -2.0% | +6.1% |
| Stockholders' Equity | $607.2M | +119.7% | +216.0% |